We have five factories and 19 years of experience in plant extracts
  • 0086-571-85302990
  • sales@greenskybio.com
Hangzhou greensky,Manufacturer of botanical extract
中文
Contact US

NEWS

We are participating in exhibitions around the world and welcome your appointment. We look forward to meeting you.

Let's talk
FDA Approves Datroway as Targeted Chemotherapy for Metastatic Breast Cancer
FDA Approves Datroway as Targeted Chemotherapy for Metastatic Breast Cancer
The Food and Drug Administration (FDA) has approved Datroway (datopotamab deruxtecan), a new chemotherapy drug designed to treat adults with unresectable or metastatic hormone receptor (HR)-positive, HER2-negative breast cancer. This approval provides a new option for patients wh...
DATE:2025-03-25
MORE
Heavy Cannabis Use Linked to Memory Deficits and Brain Function Changes
Heavy Cannabis Use Linked to Memory Deficits and Brain Function Changes
Emerging research continues to uncover potential risks associated with heavy cannabis use, including stroke and heart attack. Now, a new study published in JAMA Network Open suggests that frequent cannabis use may significantly impair the brain’s working memory, raising concerns ...
DATE:2025-03-25
MORE
FDA Expands Approval of Ketamine-Derived Spravato for Treatment-Resistant Depression
FDA Expands Approval of Ketamine-Derived Spravato for Treatment-Resistant Depression
The U.S. Food and Drug Administration (FDA) has expanded its approval of Spravato (esketamine), a ketamine-derived nasal spray, allowing its use as a standalone therapy for adults suffering from treatment-resistant depression (TRD). Previously, patients using Spravato were requir...
DATE:2025-03-25
MORE
Can Statins Protect Against Dementia?
Can Statins Protect Against Dementia?
Statins are widely recognized for their ability to lower cholesterol levels and reduce cardiovascular risks, but researchers are increasingly exploring whether these medications might also support brain health.A recent meta-analysis from Brazil sheds light on this possibility. An...
DATE:2025-03-25
MORE
FDA Approves Non-Opioid Painkiller Journavx to Combat Acute Pain Without Addiction Risk
FDA Approves Non-Opioid Painkiller Journavx to Combat Acute Pain Without Addiction Risk
The U.S. Food and Drug Administration (FDA) has approved Journavx (suzetrigine), a newly developed non-opioid pain medication designed to treat moderate-to-severe acute pain in adults. Unlike opioids, Journavx does not pose a risk of addiction, making it a transformative step in ...
DATE:2025-03-25
MORE
FDA Approves Ozempic for Patients with Type 2 Diabetes and Chronic Kidney Disease
FDA Approves Ozempic for Patients with Type 2 Diabetes and Chronic Kidney Disease
The Food and Drug Administration (FDA) has approved Ozempic (semaglutide) to reduce the risk of complications and death in adults who have both type 2 diabetes and chronic kidney disease. This approval establishes Ozempic as the first GLP-1 treatment specifically targeting patien...
DATE:2025-03-25
MORE
PFAS Contamination in Tap Water: What You Need to Know
PFAS Contamination in Tap Water: What You Need to Know
The presence of "forever chemicals," scientifically known as per- and poly-fluoroalkyl substances (PFAS), in drinking water has raised significant public health concerns in recent years. Linked to cancer, elevated cholesterol, and low birth weights, these synthetic che...
DATE:2025-03-25
MORE
New Hope for Alzheimer’s Treatment
New Hope for Alzheimer’s Treatment
By 2060, nearly 14 million Americans are projected to be living with Alzheimer’s disease, a condition that slowly erodes memory, cognitive function, independence, and personal relationships. Despite decades of research, scientists have yet to find a cure for this devastating illn...
DATE:2025-03-25
MORE
  • Home
  • Previous
  • 16
  • 17
  • 18
  • 19
  • 20
  • Next
  • Last
    • Get a Quote